Please assess the completion status of the following clinical trial:

Trial Title: Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with a proven and documented diagnosis of non Cystic Fibrosis (CF) idiopathic or post infectious bronchiectasis~* Stable pulmonary status and stable regimen of standard treatment at least for the past 4 weeks~Exclusion Criteria:~* Forced expiratory volume in 1 second (FEV1) \<30% or \>90% predicted~* Active allergic bronchopulmonary aspergillosis~* Active and actively treated non tuberculosis mycobacterial (NTM) infection or tuberculosis~* Primary diagnosis of Chronic obstructive pulmonary disease (COPD)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ciprofloxacin DPI 28 Days on/off (Cipro 28) (Type: EXPERIMENTAL): Participants received ciprofloxacin (BAYQ3939) 32.5 milligram (mg) corresponding to 50 mg dry powder for inhalation (DPI) administered twice daily (BID) (every 12 hours); a treatment cycle consisted of a 28-day on-treatment phase followed by a 28-day off-treatment phase (48 weeks treatment phase = 6 active cycles).
- Ciprofloxacin DPI 14 Days on/off (Cipro 14) (Type: EXPERIMENTAL): Participants received ciprofloxacin 32.5 mg corresponding to 50 mg DPI administered BID (every 12 hours); a treatment cycle consisted of a 14-day on-treatment phase followed by a 14-day off-treatment phase (48 weeks treatment phase = 12 active cycles).
- Placebo 28 Days on/off (Placebo 28) (Type: PLACEBO_COMPARATOR): Participants received placebo matched to ciprofloxacin 32.5 mg powder (containing 40 mg dry powder) administered BID (every 12 hours); a treatment cycle consisted of a 28-day on-treatment phase followed by a 28-day off-treatment phase (48 weeks treatment phase = 6 cycles).
- Placebo 14 Days on/off (Placebo 14) (Type: PLACEBO_COMPARATOR): Participants received placebo matched to ciprofloxacin 32.5 mg powder (containing 40 mg dry powder) administered BID (every 12 hours); a treatment cycle consisted of a 14-day on-treatment phase followed by a 14-day off-treatment phase (48 weeks treatment phase = 12 cycles).

Based on this trial design, predict the completion outcome and termination type (if applicable).